Skip to search formSkip to main contentSkip to account menu

quinine 3-monooxygenase activity

Known as: nifedipine oxidase activity, quinine 3-hydroxylase activity, quinine,NADPH:oxygen oxidoreductase activity 
Catalysis of the reaction: H(+) + NADPH + O(2) + quinine = 3-hydroxyquinine + H(2)O + NADP(+). [EC:1.14.13.67, RHEA:20152]
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Human CD34+ cells (haematopoietic stem and progenitor cells separated from peripheral blood) were shown to express CYP2E1 protein… 
2004
2004
Summary Catalytic activities of native human CYP3A4-mediated reactions as well as drug interactions were directly evaluated by… 
2000
2000
Mibefradil, a calcium Tand L-channel blocker developed for use in hypertension, was recently removed from the market after… 
1999
1999
RPR 106541 (20R-16alpha,17alpha-[butylidenebis(oxy)]-6al pha, 9alpha-difluoro-11beta-hydroxy-17beta-(methylthio)androst a-4-en-3… 
1999
1999
Summary Native human cytochrome P4503A4 was most active in nifedipine oxidation when incorporated into a binary phospholipid… 
1998
1998
Reduction of theophylline metabolism and elimination were observed in a theophylline‐treated patient during ipriflavone… 
Highly Cited
1997
Highly Cited
1997
The major metabolic pathway of quinine in the human has been shown to be 3-hydroxylation mediated mainly by human cytochrome P450… 
Highly Cited
1989
Highly Cited
1989
P-450NF is the major enzyme in human liver involved in the metabolism of the calcium-channel blocker nifedipine. By screening a…